Phaarmasia Ltd.

PHRMASI

₹27.72

5.0% (1.32)

Market Cap

₹18 Cr.

P/E

0.00

Key Ratios

Edit Ratio's

Market cap

18.00 Cr

Prom Holding

73.51 %

ROE (%)

-5.03

ROCE (%)

-4.80

Div Yield (%)

Sales

22.95 Cr

OPM (%)

-9.19 %

Debt to Equity

Edit Ratio's

About

Phaarmasia Ltd is a pharmaceutical formulations manufacturer dealing in a variety of products … Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

5 Yes

Positive for this company

1 Neutral

Neutral for this company

9 No

Negative for this company

2 No Data

Insufficient data to analyse

Accounting & Shareholding

Depreciation Effect

Depreciation accounting is not leading to increase in profits
Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Other Income

Other income component is making ratios of the company look optically better
Contingent Liabilities

Unable to calculate due to limited data

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
ROE

Asset turnover is responsible for roe increase over last 10 years
Share price

Share price has decreased over last 10 years more due to earnings
Debt

Company might have issues servicing its debt
Working Capital

Company has significant working capital which is dragging its roce and roe
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Balance Sheet Strength

Balance sheet is weak and might have solvency issues
Current vs Historic Valuation

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Phaarmasia Ltd. Business

What does Phaarmasia do?

Phaarmasia Ltd specializes in manufacturing pharmaceutical formulations like amexine, angicare, flamfort, and their therapeutic nasal spray, nasorel PR, falls under the antihistamine and sympathomimetic category.

Who are the competitors of Phaarmasia?

Phaarmasia major competitors are Norris Medicines, Shamrock Indl. Co, Saroja Pharma Ind, Link Pharma Chem, Chemo Pharma Labs, Zenith Health Care, Venmax Drugs&Pharma.
Market Cap of Phaarmasia is ₹18 Crs.
While the median market cap of its peers are ₹17 Crs.

Is Phaarmasia financially stable compared to its competitors?

Phaarmasia seems to be less financially stable compared to its competitors.
Altman Z score of Phaarmasia is 1.34 and is ranked 4 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Phaarmasia Ltd.

Phaarmasia Ltd.

Key Ratios

About

Timeline

Company Timeline

5 Yes

1 Neutral

9 No

2 No Data

Accounting & Shareholding

Depreciation Effect

Pledge

Revenue Recognition

Promoter Holding

Retail Holding

Other Income

Contingent Liabilities

Price & Performance

Capex vs ROCE

ROE

Share price

Debt

Working Capital

Sales Growth

Margin Stability

ROCE Strength

Balance Sheet Strength

Current vs Historic Valuation

Product Wise Break-Up

UNLOCK PREMIUM

What does Phaarmasia do?

Who are the competitors of Phaarmasia?

Is Phaarmasia financially stable compared to its competitors?

SIGN UP FOR FREE